Fentanyl Transdermal System (Duragesic)

Postmarket Drug Safety Information for Patients and Providers > Fentanyl Transdermal System (marketed as Duragesic) Information.

Avandia increased cardiovascular risk

but benefit outweighs risk: US  FDA Nature Medicine.

February 18, 2010 FDA Asthma warning:  Long-Acting Beta-Agonists (LABA)  risk of severe exacerbation  in long term use due to tachyphylaxispage page 6 , UPDATE 3-15-2010


public domain, may be used without permission –  except those materials noted for further reproduction is prohibited without permission of copyright holders.

%d Bloggern gefällt das: